Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Cue Biopharma, Inc. (CUE) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/03/2023 SC 13G/A STATE STREET CORP reports a 0.3% stake in EXIT FILING CUE BIOPHARMA INC
12/02/2022 SC 13G/A Nantahala Capital Management, LLC reports a 0.3% stake in Cue Biopharma, Inc.
02/14/2022 SC 13G/A Corriente Advisors, LLC reports a 0% stake in Cue Biopharma, Inc.
02/14/2022 SC 13G/A Nantahala Capital Management, LLC reports a 8% stake in Cue Biopharma, Inc.
02/03/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/29/2021 SC 13G/A BlackRock Inc. reports a 7.1% stake in CUE BIOPHARMA INC
02/14/2019 SC 13G/A STROME MARK E reports a 3.9% stake in Cue Biopharma, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy